Global Gastrointestinal Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026

May 2020 | 90 pages | ID: GB810EFFEE0DEN
QYResearch

Abstracts

This report focuses on the global Gastrointestinal Therapeutics and Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastrointestinal Therapeutics and Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Abbott Laboratories
• AstraZeneca
• Eisai
• Johnson & Johnson
• Salix Pharmaceuticals
• Takeda Pharmaceutical Company
• ...

Market segment by Type, the product can be split into

• Diagnostics
• Therapeutics

Market segment by Application, split into

• Gastroenteritis
• GI Bleeding
• Irritable Bowel Syndrome
• Peptic Ulcer Disease (PUD)
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Gastrointestinal Therapeutics and Diagnostics status, future forecast, growth opportunity, key market and key players.
• To present the Gastrointestinal Therapeutics and Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Gastrointestinal Therapeutics and Diagnostics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Therapeutics and Diagnostics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Diagnostics
  1.4.3 Therapeutics
1.5 Market by Application
  1.5.1 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application: 2020 VS 2026
  1.5.2 Gastroenteritis
  1.5.3 GI Bleeding
  1.5.4 Irritable Bowel Syndrome
  1.5.5 Peptic Ulcer Disease (PUD)
  1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Gastrointestinal Therapeutics and Diagnostics Market Perspective (2015-2026)
2.2 Gastrointestinal Therapeutics and Diagnostics Growth Trends by Regions
  2.2.1 Gastrointestinal Therapeutics and Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Gastrointestinal Therapeutics and Diagnostics Historic Market Share by Regions (2015-2020)
  2.2.3 Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Gastrointestinal Therapeutics and Diagnostics Market Growth Strategy
  2.3.6 Primary Interviews with Key Gastrointestinal Therapeutics and Diagnostics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Market Size
  3.1.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue (2015-2020)
  3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio
  3.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics and Diagnostics Revenue in 2019
3.3 Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Area Served
3.4 Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
3.5 Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2021-2026)

5 GASTROINTESTINAL THERAPEUTICS AND DIAGNOSTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)
5.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
6.2 Gastrointestinal Therapeutics and Diagnostics Key Players in North America (2019-2020)
6.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
6.4 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
7.2 Gastrointestinal Therapeutics and Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
7.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

8 CHINA

8.1 China Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
8.2 Gastrointestinal Therapeutics and Diagnostics Key Players in China (2019-2020)
8.3 China Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
8.4 China Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
9.2 Gastrointestinal Therapeutics and Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
9.4 Japan Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
10.2 Gastrointestinal Therapeutics and Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

11 INDIA

11.1 India Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
11.2 Gastrointestinal Therapeutics and Diagnostics Key Players in India (2019-2020)
11.3 India Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
11.4 India Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
12.2 Gastrointestinal Therapeutics and Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Details
  13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Introduction
  13.1.4 Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020))
  13.1.5 Abbott Laboratories Recent Development
13.2 AstraZeneca
  13.2.1 AstraZeneca Company Details
  13.2.2 AstraZeneca Business Overview and Its Total Revenue
  13.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Introduction
  13.2.4 AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
  13.2.5 AstraZeneca Recent Development
13.3 Eisai
  13.3.1 Eisai Company Details
  13.3.2 Eisai Business Overview and Its Total Revenue
  13.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Introduction
  13.3.4 Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
  13.3.5 Eisai Recent Development
13.4 Johnson & Johnson
  13.4.1 Johnson & Johnson Company Details
  13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Introduction
  13.4.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
  13.4.5 Johnson & Johnson Recent Development
13.5 Salix Pharmaceuticals
  13.5.1 Salix Pharmaceuticals Company Details
  13.5.2 Salix Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Introduction
  13.5.4 Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
  13.5.5 Salix Pharmaceuticals Recent Development
13.6 Takeda Pharmaceutical Company
  13.6.1 Takeda Pharmaceutical Company Company Details
  13.6.2 Takeda Pharmaceutical Company Business Overview and Its Total Revenue
  13.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Introduction
  13.6.4 Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
  13.6.5 Takeda Pharmaceutical Company Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Gastrointestinal Therapeutics and Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Gastrointestinal Therapeutics and Diagnostics Revenue
Table 3. Ranking of Global Top Gastrointestinal Therapeutics and Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnostics
Table 6. Key Players of Therapeutics
Table 7. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Gastrointestinal Therapeutics and Diagnostics Market Growth Strategy
Table 17. Main Points Interviewed from Key Gastrointestinal Therapeutics and Diagnostics Players
Table 18. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players (2015-2020)
Table 20. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2019)
Table 21. Global Gastrointestinal Therapeutics and Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
Table 24. Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Type (2015-2020)
Table 28. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2021-2026)
Table 29. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application (2015-2020)
Table 30. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Gastrointestinal Therapeutics and Diagnostics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Gastrointestinal Therapeutics and Diagnostics Market Share (2019-2020)
Table 34. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 36. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 38. Europe Key Players Gastrointestinal Therapeutics and Diagnostics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Gastrointestinal Therapeutics and Diagnostics Market Share (2019-2020)
Table 40. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 42. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 44. China Key Players Gastrointestinal Therapeutics and Diagnostics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Gastrointestinal Therapeutics and Diagnostics Market Share (2019-2020)
Table 46. China Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 47. China Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 48. China Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 49. China Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 50. Japan Key Players Gastrointestinal Therapeutics and Diagnostics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Gastrointestinal Therapeutics and Diagnostics Market Share (2019-2020)
Table 52. Japan Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 54. Japan Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Gastrointestinal Therapeutics and Diagnostics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Gastrointestinal Therapeutics and Diagnostics Market Share (2019-2020)
Table 58. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 60. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 62. India Key Players Gastrointestinal Therapeutics and Diagnostics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Gastrointestinal Therapeutics and Diagnostics Market Share (2019-2020)
Table 64. India Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 65. India Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 66. India Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 67. India Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Gastrointestinal Therapeutics and Diagnostics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Gastrointestinal Therapeutics and Diagnostics Market Share (2019-2020)
Table 70. Central & South America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 72. Central & South America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Product
Table 77. Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020) (Million US$)
Table 78. Abbott Laboratories Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Product
Table 82. AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020) (Million US$)
Table 83. AstraZeneca Recent Development
Table 84. Eisai Company Details
Table 85. Eisai Business Overview
Table 86. Eisai Product
Table 87. Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020) (Million US$)
Table 88. Eisai Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Recent Development
Table 94. Salix Pharmaceuticals Company Details
Table 95. Salix Pharmaceuticals Business Overview
Table 96. Salix Pharmaceuticals Product
Table 97. Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020) (Million US$)
Table 98. Salix Pharmaceuticals Recent Development
Table 99. Takeda Pharmaceutical Company Company Details
Table 100. Takeda Pharmaceutical Company Business Overview
Table 101. Takeda Pharmaceutical Company Product
Table 102. Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020) (Million US$)
Table 103. Takeda Pharmaceutical Company Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Diagnostics Features
Figure 3. Therapeutics Features
Figure 4. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Gastroenteritis Case Studies
Figure 6. GI Bleeding Case Studies
Figure 7. Irritable Bowel Syndrome Case Studies
Figure 8. Peptic Ulcer Disease (PUD) Case Studies
Figure 9. Others Case Studies
Figure 10. Gastrointestinal Therapeutics and Diagnostics Report Years Considered
Figure 11. Global Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Regions: 2020 VS 2026
Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players in 2019
Figure 16. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue in 2019
Figure 18. North America Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbott Laboratories Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
Figure 27. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
Figure 29. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Eisai Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
Figure 31. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
Figure 33. Salix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
Figure 35. Takeda Pharmaceutical Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Takeda Pharmaceutical Company Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed